Status:
NOT_YET_RECRUITING
Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction.
Lead Sponsor:
Swansea University
Conditions:
Pelvic-floor Disorders
Eligibility:
FEMALE
18+ years
Brief Summary
Pelvic-floor muscle dysfunction (PFMD) affects 25% of women. It involves urinary and faecal incontinence, prolapse, sexual dysfunction, pelvic pain, and is associated with psycho-social issues (depres...
Detailed Description
Approximately 700 women with pelvic-floor muscle dysfunction (PFMD), consecutively referred to the Women's Health Unit at Singleton Hospital, Swansea, will be given full information about the study at...
Eligibility Criteria
Inclusion
- Females
- Over 18 years old
- Diagnosed with pelvic floor muscle dysfunction
- Patients referred for physiotherapy treatment at the Women's Health Unit of Singleton Hospital, Swansea
Exclusion
- Patients under 18
- Patients who don't have PFMD
- Patients unable to give informed consent
Key Trial Info
Start Date :
April 29 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06961513
Start Date
April 29 2025
End Date
April 30 2030
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singleton Hospital
Swansea, United Kingdom, SA2 5QA